FIELD: biotechnology.
SUBSTANCE: dendritic cells obtained in a certain way are used as part of a pharmaceutical composition or kit for controlled expression of a polypeptide having the function of interleukin-12 (IL-12) in the presence of an activating ligand.
EFFECT: invention effectively inhibits tumour growth in mammals.
36 cl, 18 dwg, 5 ex
| Title |
Year |
Author |
Number |
| MODIFIED DENDRITE CELLS AND THEIR USE IN TREATMENT OF MALIGNANT TUMOURS |
2008 |
- Brauler Dzh. Mark
- Kumar Prasanna
- Storkus Uolter Dzh.
- Okada Khidekho
|
RU2484132C2 |
| MODIFIED DENDRITIC CELLS AND USE THEREOF IN TREATING MALIGNANT TUMOURS |
2017 |
- Brauler Dzh. Mark
- Kumar Prasanna
- Storkus Uolter Dzh.
- Okada Khidekho
|
RU2711606C2 |
| VECTORS CONDITIONALLY EXPRESSING THERAPEUTIC PROTEINS, HOST CELLS COMPRISING THE VECTORS, AND USES THEREOF |
2011 |
|
RU2612788C2 |
| CONSTRUCTED CELLS, EXPRESSING MULTIPLE IMMUNOMODULATORS, AND THEREOF APPLICATION |
2009 |
- Bich Robert Patterson
- Rid Tomas D.
|
RU2573912C2 |
| COMPOSITIONS AND METHODS OF IMMUNOTHERAPY |
2014 |
- Brentdzhens Rener Dzh.
- Dzhekson Kholli Dzh.
|
RU2680010C2 |
| MODIFIED MONOCYTES/MACROPHAGES EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND THEIR APPLICATIONS |
2016 |
- Gill, Saar
- Klichinsky, Michael
- June, Carl H.
|
RU2766690C2 |
| SEQUENCE DISPOSED UPSTREAM FROM CARP GENE, VECTOR CONTAINING THE SAME AND USES THEREOF |
2001 |
- Benua Patrik
- Shvarts Bertran
- Branellek Did'E
- Chiehn' Kennet
- Chehn' Tszjuj
|
RU2283865C2 |
| TRANSPOSASE POLYPEPTIDES AND USE THEREOF |
2016 |
- Belousova, Natalya
- Cooper, Laurence, J.
|
RU2735700C2 |
| T CELL RECEPTOR-DEFICIENT T CELL COMPOSITIONS |
2013 |
|
RU2653761C2 |
| METHODS AND COMPONENTS FOR INDUCTION OF TUMOR- -SPECIFIC CYTOTOXICITY |
1998 |
- Khokhberg Abrakham
- Ajesh Sukhail
|
RU2214280C2 |
